Koesten, Hirschmann & Crabtree »

Fs Global Cr Opportunitie Fda shares owned by Koesten, Hirschmann & Crabtree

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Koesten, Hirschmann & Crabtree from 13F filings

Historical chart of Koesten, Hirschmann & Crabtree investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Koesten, Hirschmann & Crabtree consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Koesten, Hirschmann & Crabtree

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.4k 1.7k 5.67
2023-09-30 $9.0k 1.7k 5.42
2023-06-30 $7.9k 1.7k 4.75
2023-03-31 $7.3k 1.7k 4.44
2022-12-31 $7.8k 1.7k 4.71

More positions owned by Koesten, Hirschmann & Crabtree

Schwab Strategic Tr Schwab Fdt Us Lg (FNDX)
Vanguard Index Fds Large Cap Etf (VV)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Small Cp Etf (VB)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core S&p Scp Etf (IJR)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Apple (AAPL)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Koesten, Hirschmann & Crabtree

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Nomura Holdings
Cambridge Investment Research Advisors
Thomas J. Herzfeld Advisors
Saba Capital Management
Wagner Wealth Management
LPL Financial
Penserra Capital Management
H D Vest Advisory Services
Advisor Group Holdings
Rockefeller Capital Management
Royal Bank of Canada
Kestra Advisory Services
Ellis Investment Partners
Prime Capital Investment Advisors

View all funds holding Fs Global Cr Opportunitie Fda